Metabolize
Science-backed metabolic health products licensed from Stanford Medicine research
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Metabolize is a San Francisco consumer health company developing Precision Metabolite products based on licensed Stanford Medicine research on naturally occurring metabolites. Its first product, NATLEAN, is planned to launch in January 2027 and is aimed at people coming off GLP-1 medications who want support managing appetite and weight. In October 2026 Metabolize announced a $3.2M seed round led by Astanor, with Maia Ventures, LongGame Venture and SOSV participating.
- Website
- metabolize.life
- Stage
- seed
- Location
- San Francisco, CA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
For people
- Homepagemetabolize.life
For agents
Nothing listed yet.
Products
- NATLEAN — Metabolite-based support for appetite and weight after GLP-1 therapy · Other